- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01773291
Adjuvant Acupuncture for Severe Head Injury
Adjuvant Acupuncture Therapy in Patients With Severe Head Injury: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: To investigate the therapeutic effect of acupuncture on severe head injury under conventional treatment.
Methods: 90 subjects aged 12 to 70 years with severe head injury (Glasgow coma scale score 8 or less) are randomly divided into acupuncture, laser acupuncture and control group. We use restoring consciousness acupuncture (GV26 and 12 Well points) to treat the subjects 3 sessions per week under conventional treatment at Department of Neurosurgery. A double-blind clinical trial is conducted up to 6 weeks and the change of subjects' GCS and muscle power is measured.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kaohsiung, Taiwan, 833
- Kaohsiung Chang Gung Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- subjects aged 12 to 70 years with severe head injury (Glasgow coma scale score 8 or less)
- with informed consent
Exclusion Criteria:
- dilated pupils without light reflex
- serious complications during therapeutic course
- interruption of therapeutic course
- unfavored condition assessed by physician in charge
- without informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: acupuncture
acupuncture on GV26 and 12 Well points
|
acupuncture on GV26 and 12 Well points
|
|
Experimental: laser acupuncture
laser acupuncture on GV26 and 12 Well points
|
laser acupuncture on GV26 and 12 Well points
|
|
Sham Comparator: control group
laser acupuncture without laser output in control group.
|
sham laser acupuncture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glasgow Coma Scale (GCS)
Time Frame: 6 weeks
|
Eye response (E) There are four grades starting with the most severe:
There are five grades starting with the most severe:
There are six grades:
The sum of the score was measured (3 - 15) before and after treatment during hospitalization. The higher score, the better outcome. |
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle Power (MP)
Time Frame: 6 weeks
|
Medical Research Council (MRC) muscle-grading scale Grade MRC grade of muscle strength 0 No movement
The 4 muscle groups were assessed on the 0 to 5 scale and scores were summed before and after treatment during hospitalization. The total score ranges from 0-20, with higher score indicating better outcome. |
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wen-Long Hu, MS, Chang Gung Memorial Hospital
Publications and helpful links
General Publications
- DeFina PA, Fellus J, Thompson JW, Eller M, Moser RS, Frisina PG, Schatz P, Deluca J, Zigarelli-McNish M, Prestigiacomo CJ. Improving outcomes of severe disorders of consciousness. Restor Neurol Neurosci. 2010;28(6):769-80. doi: 10.3233/RNN-2010-0548.
- Jennett B, Adams JH, Murray LS, Graham DI. Neuropathology in vegetative and severely disabled patients after head injury. Neurology. 2001 Feb 27;56(4):486-90. doi: 10.1212/wnl.56.4.486.
- Clauss R, Nel W. Drug induced arousal from the permanent vegetative state. NeuroRehabilitation. 2006;21(1):23-8.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMRPG8B1211
- 103-5150C (Other Identifier: Chang Gung Medical Foundation Institutional Review Board)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.